KCNQ3 Gene

📖 Wiki Page

gene1086 wordssynced 2026-04-02

KCNQ3 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNQ3 — Potassium Voltage-Gated Channel Subfamily Q Member 3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNQ3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Voltage-Gated Channel Subfamily Q Member 3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>8q24.22</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3786" target="_blank">3786</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160" target="_blank">ENSG00000184160</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/121201" target="_blank">121201</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O43525" target="_blank">O43525</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Benign Familial Neonatal Seizures, Epilepsy, Early Infantile Epileptic Encephalopathy</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Substantia Nigra, [Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus)</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">G310V, R230G, D305G, W344R</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" s

...

KCNQ3 Gene

KCNQ3 — Potassium Voltage-Gated Channel Subfamily Q Member 3

Overview

Mermaid diagram (expand to render)

KCNQ3 (Potassium Voltage-Gated Channel Subfamily Q Member 3, also known as Kv7.3) is a gene located on chromosome 8q24.22 that encodes a voltage-gated potassium channel protein essential for neuronal excitability regulation. The KCNQ3 protein forms heteromeric M-channels (M-currents) with [KCNQ2](/proteins/kcnq2-protein) subunits, which are critical for controlling neuronal resting membrane potential and preventing hyperexcitability [@jentsch2000]. Mutations in KCNQ3 are primarily associated with Benign Familial Neonatal Seizures (BFNS) and various forms of epilepsy, but emerging research suggests potential roles in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [@plant2016].

The gene is catalogued as NCBI Gene ID [3786](https://www.ncbi.nlm.nih.gov/gene/3786), Ensembl ID ENSG00000184160, OMIM [121201](https://omim.org/entry/121201), and UniProt [O43525](https://www.uniprot.org/uniprot/O43525).

Function

M-Channel Biology

The KCNQ3 protein is a core component of the voltage-gated potassium channel subfamily Q, specifically the M-channel (Kv7.2/Kv7.3 channel). M-channels are slowly activating and deactivating potassium channels that regulate neuronal excitability by controlling the resting membrane potential [@jentsch2000]. When KCNQ2/3 channels open, they allow potassium efflux, which hyperpolarizes the neuron and makes it less likely to fire action potentials. This function is crucial for:

Neuronal resting membrane potential maintenance: KCNQ2/3 channels contribute to the M-current, which sets the resting membrane potential around -70 mV in [neurons](/entities/neurons)
Action potential threshold regulation: By controlling M-current properties, these channels influence how easily neurons can fire action potentials
Repetitive firing regulation: M-channels limit high-frequency action potential generation, preventing neuronal hyperexcitability

Brain Expression

KCNQ3 is widely expressed throughout the central nervous system with high expression in:

Cortex: Both layer 5 pyramidal neurons and interneurons express KCNQ3, contributing to cortical circuit excitability
Hippocampus: CA1 and CA3 pyramidal neurons show strong KCNQ3 expression, particularly in dendrites where they regulate synaptic integration
Substantia Nigra: Dopaminergic neurons in the substantia pars compacta express KCNQ3, which may influence their vulnerability in [Parkinson's disease](/diseases/parkinsons-disease)
Thalamus: Thalamic relay neurons express KCNQ3, contributing to thalamocortical rhythm regulation
Brainstem: Respiratory and cardiovascular control centers express KCNQ3

Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=KCNQ3).

Protein Structure

The KCNQ3 protein contains six transmembrane domains (S1-S6), with the S4 segment serving as the voltage sensor. The pore region is formed between S5 and S6 segments, and the channel assembles as a tetramer. The N-terminus and C-terminus contain domains important for channel trafficking, assembly, and modulation.

Disease Associations

Benign Familial Neonatal Seizures (BFNS)

KCNQ3 mutations account for approximately 10-15% of BFNS cases, a genetic epilepsy syndrome characterized by seizures that begin in the first week of life and typically resolve by 4-24 months [@schroeder1998]. Most BFNS-causing mutations result in loss-of-function of the M-channel, reducing the M-current by 25-50%. Key BFNS-associated mutations include:

G310V: Located in the S4-S5 linker, this mutation reduces channel open probability
R230G: Disrupts voltage sensor function
D305G: Affects channel gating

Early Infantile Epileptic Encephalopathy (EIEE)

More severe de novo KCNQ3 mutations can cause EIEE, formerly known as Ohtahara syndrome, characterized by severe early-onset seizures and developmental regression [@weckhuysen2013]. These mutations often cause more severe channel dysfunction than BFNS mutations.

Alzheimer's Disease

Emerging evidence links KCNQ channel dysfunction to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

[Amyloid-beta](/proteins/amyloid-beta) effects: Aβ oligomers can enhance M-current activity in hippocampal neurons, paradoxically reducing neuronal excitability and contributing to cognitive deficits [@plant2016]
[Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) may interact with KCNQ3 and alter its subcellular localization
Neuronal hyperexcitability: While early AD shows reduced excitability, later stages feature network hyperexcitability that may involve KCNQ channel dysregulation

Parkinson's Disease

KCNQ3 may play a protective role in [dopaminergic neurons](/cell-types/dopaminergic-neurons) vulnerable in [Parkinson's disease](/diseases/parkinsons-disease):

Oxidative stress protection: KCNQ channels may help neurons withstand oxidative stress through membrane potential regulation
Excitotoxicity prevention: By limiting calcium influx through voltage-gated calcium channels (secondary to M-current regulation), KCNQ3 may protect dopaminergic neurons
Mitochondrial function: Some studies suggest KCNQ channels interact with mitochondrial proteins

Therapeutic Implications

Potassium Channel Openers

Retigabine (ezogabine), a KCNQ2/3 channel opener, has been investigated for neurological conditions:

Anti-epileptic effects: Retigabine enhances M-current and reduces neuronal hyperexcitability [@gunthorpe2012]
Neuroprotective potential: By reducing excitotoxicity, KCNQ openers may protect against neurodegeneration

Drug Development Challenges

Selectivity: Developing KCNQ3-selective modulators over KCNQ2/5 is challenging
Side effects: KCNQ channel activation can cause dizziness, tremor, and weight gain
[Blood-brain barrier](/entities/blood-brain-barrier) penetration: CNS delivery remains a key challenge

Key Mutations

| Mutation | Location | Effect |
|----------|----------|--------|
| G310V | S4-S5 linker | Reduced open probability |
| R230G | S4 voltage sensor | Altered voltage dependence |
| D305G | S5 domain | Gating defect |
| W344R | S6 domain | Dominant-negative effect |

Interactions

Protein Interactions

KCNQ2: Core subunit for M-channel formation [@jentsch2000]
KCNQ5: Can form heteromeric channels in some brain regions
Calmodulin: Regulates KCNQ3 trafficking and function
PIEZO1: Mechanical sensitivity may modulate KCNQ3 activity

Signaling Pathways

cAMP/PKA: PKA phosphorylation reduces M-current
PI3K/Akt: Akt can phosphorylate and enhance KCNQ3 function
Calcium: Calcium-activated signaling modulates M-channel activity

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/3786](https://www.ncbi.nlm.nih.gov/gene/3786)
Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160)
OMIM: [https://omim.org/entry/121201](https://omim.org/entry/121201)
UniProt: [https://www.uniprot.org/uniprot/O43525](https://www.uniprot.org/uniprot/O43525)
Allen Human Brain Atlas: [KCNQ3 expression](https://human.brain-map.org/microarray/search/show?search_term=KCNQ3)

References

[Unknown, Jentsch, T.J. (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nature Reviews Neuroscience, 1(1), 21-30 (2000)](https://pubmed.ncbi.nlm.nih.gov/11252739/)

[Plant, L.D. et al., (2016). A common mechanism for amyloid-beta effects on potassium channel function in Alzheimer's disease. Proceedings of the National Academy of Sciences, 113(31), E4405-E4414 (2016)](https://pubmed.ncbi.nlm.nih.gov/27457957/)

Schroeder, B.C. et al., (1998). Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 channels in BFNE. Nature, 396(6712), 687-690 (1998)

Weckhuysen, S. et al., (2013). KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Annals of Neurology, 73(1), 5-17 (2013)

[Gunthorpe, M.J. et al., (2012). The evolution of retigabine. Nature Reviews Drug Discovery, 11(2), 141-168 (2012)](https://pubmed.ncbi.nlm.nih.gov/22212679/)

Pathway Diagram

The following diagram shows the key molecular relationships involving KCNQ3 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

KCNQ3 Gene

KCNQ3 Gene

KCNQ3 Gene

KCNQ3 — Potassium Voltage-Gated Channel Subfamily Q Member 3

Overview

Function

M-Channel Biology

Brain Expression

Protein Structure

Disease Associations

Benign Familial Neonatal Seizures (BFNS)

Early Infantile Epileptic Encephalopathy (EIEE)

Alzheimer's Disease

Parkinson's Disease

Therapeutic Implications

Potassium Channel Openers

Drug Development Challenges

Key Mutations

Interactions

Protein Interactions

Signaling Pathways

External Links

See Also

References

Pathway Diagram